International Biotechnology Trust as of March 31, 2020
Portfolio Holdings for International Biotechnology Trust
International Biotechnology Trust holds 56 positions in its portfolio as reported in the March 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Vertex Pharmaceuticals Incorporated (VRTX) | 8.4 | $19M | 78k | 237.94 | |
| Gilead Sciences (GILD) | 8.1 | $18M | 237k | 74.67 | |
| Biogen Idec (BIIB) | 6.6 | $15M | 46k | 316.37 | |
| BioMarin Pharmaceutical (BMRN) | 6.5 | $14M | 170k | 84.45 | |
| ACADIA Pharmaceuticals (ACAD) | 6.5 | $14M | 337k | 42.23 | |
| Amgen (AMGN) | 6.1 | $13M | 66k | 202.73 | |
| Ptc Therapeutics I (PTCT) | 5.5 | $12M | 269k | 44.50 | |
| Horizon Therapeutics | 5.3 | $12M | 394k | 29.60 | |
| Neurocrine Biosciences (NBIX) | 4.2 | $9.3M | 107k | 86.56 | |
| Chemocentryx | 3.5 | $7.6M | 190k | 40.15 | |
| Incyte Corporation (INCY) | 3.3 | $7.3M | 100k | 73.23 | |
| Zogenix | 3.2 | $7.0M | 282k | 24.68 | |
| Alexion Pharmaceuticals | 3.0 | $6.6M | 74k | 89.77 | |
| Seattle Genetics | 3.0 | $6.6M | 57k | 115.24 | |
| Merck & Co (MRK) | 2.9 | $6.4M | 83k | 76.96 | |
| Halozyme Therapeutics (HALO) | 2.5 | $5.5M | 308k | 17.98 | |
| Mirati Therapeutics | 1.5 | $3.4M | 44k | 76.86 | |
| Eli Lilly & Co. (LLY) | 1.3 | $2.8M | 20k | 138.50 | |
| Sarepta Therapeutics (SRPT) | 1.3 | $2.7M | 28k | 97.65 | |
| Ionis Pharmaceuticals (IONS) | 1.2 | $2.5M | 54k | 47.28 | |
| Alnylam Pharmaceuticals (ALNY) | 1.1 | $2.4M | 22k | 108.74 | |
| Enanta Pharmaceuticals (ENTA) | 1.1 | $2.4M | 47k | 51.29 | |
| Exelixis (EXEL) | 0.8 | $1.8M | 104k | 17.15 | |
| Kalvista Pharmaceuticals (KALV) | 0.8 | $1.7M | 227k | 7.62 | |
| Acceleron Pharma | 0.7 | $1.6M | 18k | 89.83 | |
| Ascendis Pharma A S (ASND) | 0.7 | $1.5M | 14k | 112.17 | |
| Turning Point Therapeutics I | 0.7 | $1.5M | 35k | 44.06 | |
| Sutro Biopharma (STRO) | 0.6 | $1.4M | 139k | 9.87 | |
| Principia Biopharma | 0.6 | $1.4M | 23k | 58.48 | |
| Uniqure Nv (QURE) | 0.6 | $1.3M | 28k | 46.87 | |
| Amarin Corporation (AMRN) | 0.6 | $1.3M | 320k | 3.98 | |
| Nektar Therapeutics (NKTR) | 0.5 | $1.2M | 67k | 17.81 | |
| Sage Therapeutics (SAGE) | 0.5 | $1.1M | 38k | 28.64 | |
| Immunomedics | 0.4 | $970k | 72k | 13.47 | |
| Millendo Therapeutics | 0.4 | $939k | 178k | 5.28 | |
| Crispr Therapeutics (CRSP) | 0.4 | $930k | 22k | 42.27 | |
| Gw Pharmaceuticals Plc ads | 0.4 | $893k | 10k | 87.55 | |
| Amicus Therapeutics (FOLD) | 0.4 | $873k | 95k | 9.23 | |
| Agios Pharmaceuticals (AGIO) | 0.3 | $762k | 22k | 35.44 | |
| Alkermes (ALKS) | 0.3 | $749k | 52k | 14.40 | |
| Myokardia | 0.3 | $743k | 16k | 46.85 | |
| Momenta Pharmaceuticals | 0.3 | $734k | 27k | 27.19 | |
| Blueprint Medicines (BPMC) | 0.3 | $700k | 12k | 58.33 | |
| Deciphera Pharmaceuticals | 0.3 | $697k | 17k | 41.00 | |
| Allakos (ALLK) | 0.3 | $692k | 16k | 44.08 | |
| Arena Pharmaceuticals | 0.3 | $690k | 17k | 41.82 | |
| Fibrogen (FGEN) | 0.3 | $684k | 20k | 34.72 | |
| Tricida | 0.3 | $635k | 29k | 21.90 | |
| EXACT Sciences Corporation (EXAS) | 0.3 | $619k | 11k | 57.85 | |
| Insmed (INSM) | 0.2 | $537k | 34k | 15.98 | |
| Bluebird Bio (BLUE) | 0.2 | $505k | 11k | 45.91 | |
| Global Blood Therapeutics In | 0.2 | $498k | 9.8k | 50.82 | |
| Intra Cellular Therapies (ITCI) | 0.2 | $352k | 23k | 15.30 | |
| Esperion Therapeutics (ESPR) | 0.1 | $298k | 9.5k | 31.37 | |
| Zealand Pharma A/s- | 0.1 | $183k | 5.7k | 32.37 | |
| Anaptysbio Inc Common (ANAB) | 0.1 | $140k | 10k | 14.00 |
